EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The role of amino bisphosphonates zoledronate and alendronate in shaping immunomodulatory profile and angiogenic potential of human periodontal ligament stem cells

Jessica Bria, Emanuela Chiarella, Jessica Sovereto, Francesco Baudi, Marta Greco, Daniela Patrizia Foti, Amerigo Giudice, Anna Di Vito iD

PLOS One · 2025

DOI: 10.1371/journal.pone.0335744 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Jessica Bria und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental and Clinical Medicine, University Magna Græcia, Catanzaro, Italy. Hauptthemen laut MEDLINE: Zoledronic Acid, Periodontal Ligament, Alendronate, Stem Cells. Die Arbeit nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero dell'Università e della Ricerca, University Magna Graecia of Catanzaro, Ph.D. Program in Molecular and Translation Oncology and Advanced Medical-Surgical Technologies.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bisphosphonate-related osteonecrosis of the jaw is a significant complication arising from the use of nitrogen-containing bisphosphonates such as Zoledronate (ZOL) and Alendronate (ALN). Although the effects of amino bisphosphonates on bone cells are well established, their influence on human periodontal ligament stem cells (hPDLSCs) remains inadequately explored. This study aimed to evaluate the influence of clinically relevant doses of ZOL and ALN on hPDLSCs secretome composition and its involvement in vascular changes reported in BRONJ. hPDLSCs isolated from the impacted third molar were exposed to increasing concentrations of ZOL (1 μM, 1.5 μM, 2 μM) or ALN (2 μM, 5 μM, 10 μM) for five days. Cytokine assay was directed to measure the levels of IL-1α, IL-6, IL-8, VEGF, and MCP-1. PD-L1 quantification was conducted by immunofluorescence, western blotting and flow cytometry. The angiogenic potential of hPDLSCs-derived secretome after preconditioning with ZOL or ALN was assessed on endothelial cells proliferation, migration, and tube-forming ability. Both ZOL and ALN treatment of hPDLSCs did not result in any significant changes in the secretion of inflammatory markers (IL-1α, IL-6, IL-8, VEGF and MCP-1). ZOL 1.5 μM ( p < 0.0001) and 2 μM ( p < 0.05) induced a down-regulation of total PD-L1. ALN 2 μM and 5 μM promoted a reduction of total ( p < 0.0001) and surface ( p < 0.01) PD-L1, whereas ALN 10 μM induced a rise in surface PD-L1 ( p < 0.0001). Conditioned medium from ZOL- or ALN-treated hPDLSCs impairs cell migration ( p < 0.05) and tube forming ability in vitro ( p < 0.05). In summary, these results suggest that therapeutic concentrations of ZOL and ALN influence the immunomodulatory ability of hPDLSCs by altering PD-L1 expression and reducing the angiogenic potential of hPDLSCs secretome. Both the modulation of inflammation and impairment of angiogenesis may induce unfavorable conditions in periodontal tissue, facilitating the development of osteonecrosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Zoledronic AcidPeriodontal LigamentAlendronateStem CellsNeovascularization, PhysiologicDiphosphonatesBone Density Conservation AgentsHumansCell ProliferationCells, CulturedCell MovementCytokinesImidazoles

Substanzen

Zoledronic AcidAlendronateDiphosphonatesCytokinesBone Density Conservation AgentsImidazoles

Autor:innen und Institutionen

  • Department of Experimental and Clinical Medicine, University Magna Græcia, Catanzaro, Italy.
  • Department of Medical and Surgical Sciences, University Magna Graecia, Catanzaro, Italy.
  • Obstetrics and Gynecology Unit, University Hospital Renato Dulbecco of Catanzaro, Catanzaro, Italy.
  • Department of Health Sciences, University Magna Græcia, Catanzaro, Italy.
  • Clinical Pathology Unit, University Hospital "Renato Dulbecco" of Catanzaro, Catanzaro, Italy.

ORCID-Profile: Anna Di Vito

Förderung

  • Ministero dell'Università e della Ricerca
  • University Magna Graecia of Catanzaro, Ph.D. Program in Molecular and Translation Oncology and Advanced Medical-Surgical Technologies

Zitieren

APA

Bria, J., Chiarella, E., Sovereto, J., Baudi, F., Greco, M., Foti, D. P., Giudice, A., & Di Vito, A. (2025). The role of amino bisphosphonates zoledronate and alendronate in shaping immunomodulatory profile and angiogenic potential of human periodontal ligament stem cells. PLOS One. https://doi.org/10.1371/journal.pone.0335744

Vancouver

Bria J, Chiarella E, Sovereto J, Baudi F, Greco M, Foti DP, et al. The role of amino bisphosphonates zoledronate and alendronate in shaping immunomodulatory profile and angiogenic potential of human periodontal ligament stem cells. PLOS One. 2025. doi:10.1371/journal.pone.0335744

BibTeX
@article{Bria2025,
  author = {Bria, Jessica and Chiarella, Emanuela and Sovereto, Jessica and Baudi, Francesco and Greco, Marta and Foti, Daniela Patrizia and Giudice, Amerigo and Di Vito, Anna},
  title = {The role of amino bisphosphonates zoledronate and alendronate in shaping immunomodulatory profile and angiogenic potential of human periodontal ligament stem cells},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0335744}
}
Kostenlos starten →